Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,210,827
  • Shares Outstanding, K 140,840
  • Annual Sales, $ 5,281 M
  • Annual Income, $ -4,012,800 K
  • 36-Month Beta 0.69
  • Price/Sales 2.31
  • Price/Cash Flow 10.71
  • Price/Book 2.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.70 +8.62%
on 11/08/17
91.73 -5.63%
on 11/09/17
+0.51 (+0.59%)
since 10/24/17
3-Month
76.10 +13.76%
on 08/30/17
91.73 -5.63%
on 11/09/17
+9.07 (+11.70%)
since 08/24/17
52-Week
63.68 +35.95%
on 08/09/17
91.73 -5.63%
on 11/09/17
-2.76 (-3.09%)
since 11/23/16

Most Recent Stories

More News
Global RX-to-OTC Switching Market Current and Future Trends Report 2017 Featuring Teva, Novartis, Bayer, Mylan, GSK, Perrigo, Valeant, Grifols & Mallinckrodt

The "Current and Future Trends in RX-to-OTC Switching with Insight from Key Industry Opinion Leaders" report has been added to Research and Markets' offering.

PRGO : 86.57 (-0.15%)
Perrigo Company Completes Divestiture Of API Business For $110 Million

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has completed the previously announced divestiture of its Active Pharmaceutical Ingredient (API) business based in Israel to SK Capital for...

PRGO : 86.57 (-0.15%)
Zacks.com featured highlights: Boot Barn, Perrigo, Boise Cascade, DXC Technology and Koppers

Zacks.com featured highlights: Boot Barn, Perrigo, Boise Cascade, DXC Technology and Koppers

BCC : 37.10 (-0.27%)
KOP : 48.70 (+0.41%)
BOOT : 13.41 (-0.59%)
DXC : 97.76 (-0.03%)
PRGO : 86.57 (-0.15%)
SK Capital Closes Acquisition of Perrigo's API Business and Changes Name to Wavelength Pharmaceuticals

SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed its previously announced acquisition of Perrigo Company plc's (NYSE;...

PRGO : 86.57 (-0.15%)
Bet on These 5 GARP Stocks Based on Low PEG Ratio

A lower PEG ratio, preferably less than 1, is always better for GARP investors.

BCC : 37.10 (-0.27%)
KOP : 48.70 (+0.41%)
BOOT : 13.41 (-0.59%)
DXC : 97.76 (-0.03%)
PRGO : 86.57 (-0.15%)
Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use

A new study conducted by researchers at the University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the...

TRVN : 1.77 (+5.36%)
CARA : 12.39 (+1.64%)
COLL : 16.81 (+3.13%)
VRTHF : 0.5523 (+38.77%)
VRT.CN : 0.600 (+11.11%)
PRGO : 86.57 (-0.15%)
Company News For Nov 10, 2017

Companies in the News are: ROKU,M,SEDG,PRGO

ROKU : 39.47 (-2.78%)
SEDG : 39.70 (+2.85%)
M : 21.07 (+2.13%)
PRGO : 86.57 (-0.15%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

PALM BEACH, Florida, November 10, 2017 /PRNewswire/ --

TRPX : 5.44 (unch)
TRVN : 1.77 (+5.36%)
CARA : 12.39 (+1.64%)
COLL : 16.81 (+3.13%)
PRGO : 86.57 (-0.15%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

According to Additions.com, Opioid addiction rates have skyrocketed over the past two decades, costing millions in health insurance costs and lost productivity in the workforce. According to Fortune magazine,...

TRPX : 5.44 (unch)
TRVN : 1.77 (+5.36%)
CARA : 12.39 (+1.64%)
COLL : 16.81 (+3.13%)
PRGO : 86.57 (-0.15%)
Perrigo (PRGO) Q3 Earnings Top, 2017 View Raised, Shares Up

Perrigo (PRGO) posts better-than-expected earnings with revenues also beating estimates. The company ups its guidance, courtesy of a continued positive execution across all business segments.

LGND : 133.71 (+0.49%)
EBS : 41.68 (+1.98%)
EXEL : 25.85 (-1.07%)
PRGO : 86.57 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Key Turning Points

2nd Resistance Point 88.14
1st Resistance Point 87.36
Last Price 86.57
1st Support Level 85.84
2nd Support Level 85.10

See More

52-Week High 91.73
Last Price 86.57
Fibonacci 61.8% 81.01
Fibonacci 50% 77.71
Fibonacci 38.2% 74.40
52-Week Low 63.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart